CMR becomes the third surgical robotics company alongside Intuitive Surgical and SHURUI Robotics to obtain a CE mark in Europe for paediatric treatment.

CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. CMR Surgical has secured US Food and Drug Administration (FDA) clearance ...

Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery Cambridge, UK – 8 January 2026, CMR Surgical (‘CMR’ or ‘the Company’), the global surgical robotics ...

CAMBRIDGE, UK – 27th March 2023, 07:00 (BST). CMR Surgical (CMR) – the global surgical robotics business – today announces that its next-generation surgical robotic system, Versius ®, has been used to ...

After a record quarter, CMR closes the year with a Versius global install base more than 50% higher than 2022 Over 17,000 surgical procedures completed using Versius, representing a procedural growth ...

insights from industryMark SlackChief Medical OfficerCMR Surgical In this interview, we speak to Mark Slack, Chief Medical Officer at CMR Surgical, about their next-generation surgical robot Versius ...

CMR Surgical receives CE Mark for use of Versius in paediatric surgery Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery Cambridge, UK – 8 January 2026, ...